New York Eastern Bankruptcy Court

Case number: 8:10-bk-78439 - Tetragenex Pharmaceuticals, Inc. - New York Eastern Bankruptcy Court

Case Information
Case title
Tetragenex Pharmaceuticals, Inc.
Court
New York Eastern (nyebke)
Chapter
11
Filed
10/26/2010
Asset
Yes
Docket Header

Repeat, CLOSED




U.S. Bankruptcy Court
Eastern District of New York (Central Islip)
Bankruptcy Petition #: 8-10-78439-reg

Assigned to: Robert E. Grossman
Chapter 11
Voluntary
Asset



Debtor disposition:  Discharge Not Applicable
Date filed:  10/26/2010
Date terminated:  01/18/2012
Plan confirmed:  01/06/2011
341 meeting:  12/03/2010

Debtor

Tetragenex Pharmaceuticals, Inc.

6901 Jericho Turnpike
Suite 221
Jericho, NY 11791
NASSAU-NY
Tax ID / EIN: 22-3781895
fka
Innapharma, Inc.
represented by
Paul Rachmuth

Gersten Savage LLP
600 Lexington Avenue
New York, NY 10022
212-752-9700
Fax : 212-980-5192
Email: [email protected]

U.S. Trustee

United States Trustee

Long Island Federal Courthouse
560 Federal Plaza - Room 560
Central Islip, NY 11722-4437
(631) 715-7800
 
 

Latest Dockets
Date Filed#Docket Text
01/18/2012Docket Text
Bankruptcy Case Closed (ssw) (Entered: 01/18/2012)
01/04/2012Docket Text
ENTERED IN ERROR- Bankruptcy Case Closed (ssw) Modified on 1/4/2012 (ssw). (Entered: 01/04/2012)
01/03/201246Docket Text
Final Decree Chapter 11 Signed on 1/3/2012 ; This Chapter 11 Bankruptcy Case be closed (RE: Related Document 45Motion for Final Decree ) (ssw) (Entered: 01/04/2012)
06/30/201145Docket Text
Application for Final DecreeFiled by Paul Rachmuth on behalf of Tetragenex Pharmaceuticals, Inc.. (Rachmuth, Paul) Modified on 7/1/2011 for clarification. (ssw). (Entered: 06/30/2011)
01/28/201144Docket Text
LetterNotice of Effective DateFiled by Paul Rachmuth on behalf of Tetragenex Pharmaceuticals, Inc. (RE: related document(s) 40Amended Chapter 11 Plan filed by Debtor Tetragenex Pharmaceuticals, Inc.) (Rachmuth, Paul) (Entered: 01/28/2011)
01/20/201143Docket Text
Monthly Operating Report for Filing Period December, 2010 Filed by Paul Rachmuth on behalf of Tetragenex Pharmaceuticals, Inc. (Attachments: 1Signature Page 2Exhibit 1 3Exhibit 2 4Exhibit 3 5Exhibit 4 6Exhibit 5 7Exhibit 6 8Exhibit 7 9Exhibit 8) (Rachmuth, Paul) (Entered: 01/20/2011)
01/08/201142Docket Text
BNC Certificate of Mailing with Notice of Order Confirming Ch 11 Plan Service Date 01/08/2011. (Admin.) (Entered: 01/09/2011)
01/06/201141Docket Text
Order Approving the Disclosure Statement and Confirming Amended Prepackaged Plan of Reorganization of Tetragenex Pharmaceuticals, Inc. (RE: related document(s) 3Motion to Consider approval of Disclosure Statement and Confirmation of Plan 40Amended Chapter 11 Plan filed by Debtor Tetragenex Pharmaceuticals, Inc.). Final Decree Due on 4/6/2011. Signed on 1/6/2011. (ssw) (Entered: 01/06/2011)
01/06/201140Docket Text
Second Amended Chapter 11 Plan As Confirmed, Dated December 16, 2010 Signed by Martin Schacker Filed by Paul Rachmuth on behalf of Tetragenex Pharmaceuticals, Inc. (RE: related document(s) 31Chapter 11 Plan filed by Debtor Tetragenex Pharmaceuticals, Inc.). (Rachmuth, Paul) (Entered: 01/06/2011)
01/06/201139Docket Text
ENTERED IN ERROR (AS PER CHAMBER'S INSTRUCTION ); SEE CORRECTED ENTRY BELOW - Second Amended Chapter 11 Plan Dated December 16, 2010 Martin Schacker Filed by Paul Rachmuth on behalf of Tetragenex Pharmaceuticals, Inc. (RE: related document(s) 31Chapter 11 Plan filed by Debtor Tetragenex Pharmaceuticals, Inc.). (Rachmuth, Paul) Modified on 1/6/2011 (ssw). (Entered: 01/06/2011)